Literature DB >> 27572866

Consensus definitions for pediatric MS and other demyelinating disorders in childhood.

Marc Tardieu1, Brenda Banwell2, Jerry S Wolinsky2, Daniela Pohl2, Lauren B Krupp2.   

Abstract

In light of the published 2012 International Pediatric Multiple Sclerosis Group definitions for pediatric multiple sclerosis (MS) and related disorders and given that pediatric-onset MS is now formally included in the 2010 McDonald criteria for MS, we sought to review these criteria and summarize their application in children with acquired CNS demyelination. In addition, proposals are made for definitions of no evidence of disease activity and inadequate treatment response that are important because of new therapeutic options and trials.
© 2016 American Academy of Neurology.

Entities:  

Mesh：

Year:  2016        PMID： 27572866     DOI： 10.1212/WNL.0000000000002877

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Differential imaging of atypical demyelinating lesions of the central nervous system.

Authors:  Matteo Paoletti; Shaun Ivan Muzic; Francesca Marchetti; Lisa Maria Farina; Stefano Bastianello; Anna Pichiecchio
Journal:  Radiol Med       Date:  2021-01-24       Impact factor: 3.469

2.  Clinical Reasoning: A patient with a history of encephalomyelitis and recurrent optic neuritis.

Authors:  Josef Maxwell Gutman; Michael Levy; Steven Galetta; Ilya Kister
Journal:  Neurology       Date:  2017-11-07       Impact factor: 9.910

Review 3.  [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017].

Authors:  O Aktas; M P Wattjes; M Stangel; H-P Hartung
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

4.  Pediatric Inflammatory and Autoimmune Neurologic Disorders at a Tertiary Medical Center.

Authors:  Angela M Curcio; Jennifer M Bain; Erin S Beck; Wendy S Vargas
Journal:  J Child Neurol       Date:  2020-07-17       Impact factor: 1.987

Review 5.  Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.

Authors:  Marisa McGinley; Ian T Rossman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

6.  Cognitive Functioning in Patients with Pediatric-Onset Multiple Sclerosis, an Updated Review and Future Focus.

Authors:  Joy B Parrish; Emily Fields
Journal:  Children (Basel)       Date:  2019-02-04

7.  Management of pediatric post-infectious neurological syndromes.

Authors:  Elena Bozzola; Giulia Spina; Massimiliano Valeriani; Laura Papetti; Fabiana Ursitti; Rino Agostiniani; Cristina Mascolo; Margherita Ruggiero; Chiara Di Camillo; Anna Quondamcarlo; Luigi Matera; Davide Vecchio; Luigi Memo; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-01-25       Impact factor: 2.638

8.  Adverse childhood experiences predict reaction to multiple sclerosis diagnosis.

Authors:  Tehila Eilam-Stock; Jon Links; Nabil Z Khan; Tamar E Bacon; Guadalupe Zuniga; Lisa Laing; Carrie Sammarco; Kathleen Sherman; Leigh Charvet
Journal:  Health Psychol Open       Date:  2021-10-21

9.  Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination.

Authors:  Mihai Ancau; Friederike Liesche-Starnecker; Johanna Niederschweiberer; Sandro M Krieg; Claus Zimmer; Charlotte Lingg; Daniela Kumpfmüller; Benno Ikenberg; Markus Ploner; Bernhard Hemmer; Silke Wunderlich; Mark Mühlau; Benjamin Knier
Journal:  Front Neurol       Date:  2022-02-02       Impact factor: 4.003

Review 10.  Current Advances in Pediatric Onset Multiple Sclerosis.

Authors:  Kristen S Fisher; Fernando X Cuascut; Victor M Rivera; George J Hutton
Journal:  Biomedicines       Date:  2020-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.